Connecting you to content on EBSCOhost

Works by Nishiya, Yoichi

Results: 3

1

Safety and effectiveness of empagliflozin and linagliptin fixed-dose combination therapy in Japanese patients with type 2 diabetes: final results of a one-year post-marketing surveillance study.

Published in:

Expert Opinion on Drug Safety, 2023, v. 22, n. 2, p. 153, doi. 10.1080/14740338.2022.2107200

By:

Inagaki, Nobuya;
Nishimoto, Takaaki;
Nishiya, Yoichi;
Nitta, Daisuke

Publication type:

Article

2

Effects of sodium-glucose co-transporter 2 inhibitors on ultrafiltration in patients with peritoneal dialysis: a protocol for a randomized, double-blind, placebo-controlled, crossover trial (EMPOWERED).

Published in:

Clinical & Experimental Nephrology, 2024, v. 28, n. 7, p. 629, doi. 10.1007/s10157-024-02467-w

By:

Doi, Yohei;
Shinzawa, Maki;
Arisato, Tetsuya;
Oka, Hideaki;
Matsumoto, Ayumi;
Kitamura, Harumi;
Nakazono, Yumi;
Nishiya, Yoichi;
Ueda, Yoshiyasu;
Kamimura, Taro;
Hayashi, Terumasa;
Yoshihara, Fumiki;
Isaka, Yoshitaka

Publication type:

Article

3

The SGLT2 inhibitor empagliflozin improves cardiac energy status via mitochondrial ATP production in diabetic mice.

Published in:

Communications Biology, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s42003-023-04663-y

By:

Choi, Jungmi;
Matoba, Naoki;
Setoyama, Daiki;
Watanabe, Daiki;
Ohnishi, Yuichiro;
Yasui, Ryuto;
Kitai, Yuichirou;
Oomachi, Aki;
Kotobuki, Yutaro;
Nishiya, Yoichi;
Pieper, Michael Paul;
Imamura, Hiromi;
Yanagita, Motoko;
Yamamoto, Masamichi

Publication type:

Article